part_subject: "ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USE"
subpart_code: "C"
subpart_subject: "Labeling"
section_number: "332.31"
section_subject: "Professional labeling."
cfr_reference: "21 CFR 332.31"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 300 to 499"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
(a)The labeling of the product provided to health professionals (but not to the general public) may contain as additional indications postoperative gas pain or for use in endoscopic examination.
(b)Professional labeling for an antiflatulent-antacid combination may contain information allowed for health professionals for antacids and antiflatulents.